$256 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 63 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
JAZZ | New | Jazz Pharmaceuticals PLC | $2,867,000 | – | 19,000 | +100.0% | 1.12% | – |
RARE | New | Ultragenyx Pharmaceutical Inc | $2,090,000 | – | 41,000 | +100.0% | 0.82% | – |
AXGN | New | Axogen Inc | $1,823,000 | – | 50,000 | +100.0% | 0.71% | – |
PEN | New | Penumbra Inc | $1,618,000 | – | 14,000 | +100.0% | 0.63% | – |
XENT | New | Intersect Ent Inc | $1,452,000 | – | 37,000 | +100.0% | 0.57% | – |
GMED | New | Globus Med Inc | $1,445,000 | – | 29,000 | +100.0% | 0.56% | – |
MRUS | New | Merus N V | $1,391,000 | – | 75,060 | +100.0% | 0.54% | – |
RIGL | New | Rigel Pharmaceuticals Inc | $1,302,000 | – | 370,000 | +100.0% | 0.51% | – |
VSTM | New | Verastem Inc | $1,192,000 | – | 400,000 | +100.0% | 0.46% | – |
ESPR | New | Esperion Therapeutics Inc | $723,000 | – | 10,000 | +100.0% | 0.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
AMGEN INC COM | 25 | Q3 2023 | 7.9% |
NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-14 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-18 |
13F-HR | 2023-02-01 |
13F-HR | 2022-11-08 |
13F-HR | 2022-08-16 |
13F-HR | 2022-05-20 |
13F-HR | 2022-02-15 |
13F-HR | 2021-11-12 |
13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.